Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
2019 Full year and fourth quarter results announcement
We will announce our 2019 full year and fourth quarter results at 12:00 GMT, 07:00 EST on Wednesday 05 February.
Following the announcement there will be a webcast, hosted by Emma Walmsley, CEO; Iain Mackay, CFO; and Hal Barron, Chief Scientific Officer and President, R&D at 14:00 GMT, 09:00 EST.